Journal of the Nigerian Infectious Diseases Society

NIDS 2022 Conference Abstracts
J Nig Infect Dis Soc 2023; 2(1):A06

Pattern of Presentation of Monkey Pox Disease in a Nigerian Tertiary Hospital

Chika-Igwenyi N M 1 N M 1 NM^(1**)\mathrm{NM}^{1 *}NM1, Unigwe US 1 , 2 1 , 2 ^(1,2){ }^{1,2}1,2, Ajayi N A 1 N A 1 NA^(1)\mathrm{NA}^{1}NA1, Onwe O E 1 O E 1 OE^(1)\mathrm{OE}^{1}OE1, Ewa R L 5 R L 5 RL^(5)\mathrm{RL}^{5}RL5, Ojide C K 6 C K 6 CK^(6)\mathrm{CK}^{6}CK6, Una A F 7 A F 7 AF^(7)\mathrm{AF}^{7}AF7, Igwenyi C 1 C 1 C^(1)\mathrm{C}^{1}C1, Chukwu K S 1 K S 1 KS^(1)\mathrm{KS}^{1}KS1, Okorie G M 4 G M 4 GM^(4)\mathrm{GM}^{4}GM4, Ifebunandu N A 1 N A 1 NA^(1)\mathrm{NA}^{1}NA1, Ugwu C N 1 C N 1 CN^(1)\mathrm{CN}^{1}CN1, Emeka 8 8 ^(8){ }^{8}8, Ibemesi D 7 , N n a j i 1 T O 1 , N s i k a n P O 9 D 7 , N n a j i 1 T O 1 , N s i k a n P O 9 D^(7),Nnaji^(1)TO^(1),NsikanPO^(9)\mathrm{D}^{7}, \mathrm{Nnaji}^{1} \mathrm{TO}^{1}, \mathrm{Nsikan} \mathrm{PO}^{9}D7,Nnaji1TO1,NsikanPO9, Odianosen E 10 E 10 E^(10)\mathrm{E}^{10}E10

  1. Department of Medicine, Alex Ekwueme Federal University Teaching Hospital Abakaliki, Ebonyi State.
  2. Department of Medicine, University of Nigeria Teaching Hospital, Ituku/Ozalla, Enugu, Enugu State
  3. Department of Paediatrics, Alex Ekwueme Federal University Teaching Hospital Abakaliki, Ebonyi State.
  4. Department of Plastic Surgery, Alex Ekwueme Federal University Teaching Hospital Abakaliki, Ebonyi State.
  5. Department of Anaesthesia, Alex Ekwueme Federal University Teaching Hospital Abakaliki, Ebonyi State
  6. Department of Medical Microbiology, Alex Ekwueme Federal University Teaching Hospital Abakaliki, Ebonyi State
  7. Department of Community Medicine Alex Ekwueme Federal University Teaching Hospital Abakaliki, Ebonyi State
  8. Ministry of Health, Ebonyi State
  9. Surveillance Support Office, Ebonyi State
  10. Nigeria Center for Disease Control, Abuja

*Corresponding author:

DOI

10.58539/JNIDS.2023.2108
Abstract

Background: Human Monkeypox (MPX) is a viral zoonotic disease endemic in tropical rainforest areas of Africa and is occasionally exported to other regions of the world. Distinguishing MPX from other rash illnesses could be challenging. We describe the clinical presentation and course of confirmed human MPX patients managed in Ebonyi State.

Methods: A retrospective descriptive study conducted between August and November 2022.

Results: Out of 16 suspected cases, 12(75%) were RT-PCR confirmed positive for MPX, 4 (33%) were negative for MPX but positive for Varicella zoster virus (VZV). The mean age of the participants was 28.5 + 17 28.5 + 17 28.5+1728.5+1728.5+17 years with a range of 2 and 55 years. Of the twelve confirmed cases, 8(66.6%) were males, 4(33.3%) females and 5(41.6%) had VZV co-infection. All the patients experienced rash, 7(58%) had fever with chills, 5(41.6%) had lymphadenopathy, and 3(25%) had sore throat while 6 ( 50 % ) 6 ( 50 % ) 6(50%)6(50 \%)6(50%) had significant genital lesions. Skin lesions were typically monomorphic and involved the extremities, head and neck, chest, back, palms and sole. Thirty three percent had 5-100 lesions, and 8(66.6%) of the patients had lesions in a centrifugal distribution. The most common lesions included papules, vesicles and pustules.
Conclusions: Clinical recognition, diagnosis, and prevention of MPX still remain a concern in endemic, resource-limited settings. Public enlightenment on risk factors, enhanced surveillance, and a high index of suspicion are key to prevention, early recognition, and diagnosis of MPX. Further studies are needed to better understand the course and prevention of human infections.
Key words: Human Monkeypox, RT-PCR confirmed, clinical presentation, Ebonyi